400-920-2911 sales@csnpharm.cn
CAS No.: 1024033-43-9
AZD4017 is a potent, selective, and orally bioavailable11β-HSD1 inhibitor (11β-hydroxysteroid dehydrogenase type 1 inhibitor). Inhibition of 11β-HSD1 is an attractive mechanism for the treatment of obesity and other elements of the metabolic syndrome.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03313297 | Diabetes Mellitus, Type 2 | Phase 2 | Recruiting | April 1, 2019 | United Kingdom ... more >> Leeds Teaching Hospitals Trust Recruiting Leeds, United Kingdom, LS9 7TF Contact: Ana Tiganescu, PhD 00441133438336 a.tiganescu@leeds.ac.uk Collapse << |
NCT01173471 | Raised Intraocular Pressure | Phase 2 | Completed | - | United States, California ... more >> Research Site Newport Beach, California, United States United States, Georgia Research Site Atlanta, Georgia, United States Research Site Morrow, Georgia, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, North Carolina Research Site Charlotte, North Carolina, United States Research Site Durham, North Carolina, United States United States, Tennessee Research Site Memphis, Tennessee, United States Sweden Research Site Lund, Sweden Research Site Molndal, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Nottingham, United Kingdom Collapse << |
NCT00791752 | Healthy | Phase 1 | Completed | - | Sweden ... more >> Research Site Gotteborg, Sweden Collapse << |
实验方案
技术信息
CAS号 | 1024033-43-9 | 储存条件 |
|
|
分子式 | C22H33N3O3S | 运输 | 蓝冰 | |
分子量 | 419.58 | 别名 |